scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CANLET.2010.01.022 |
P698 | PubMed publication ID | 20153576 |
P2093 | author name string | Xu Li | |
Yan Li | |||
Xueli Fan | |||
Kazuhiro Tanaka | |||
Tomoyuki Nakamura | |||
Yukihide Iwamoto | |||
Fumihiko Nakatani | |||
Minoru Takasaki | |||
Shunsaku Yamamoto | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 57-65 | |
P577 | publication date | 2010-02-12 | |
P1433 | published in | Cancer Letters | Q326372 |
P1476 | title | Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors | |
P478 | volume | 294 |
Q35665048 | A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis |
Q38301170 | Anti-Epileptic Drug Targets Ewing Sarcoma |
Q27027664 | Children's Oncology Group's 2013 blueprint for research: bone tumors |
Q64069784 | Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line |
Q41304204 | Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family. |
Q37544326 | EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway. |
Q47891760 | Intracranial Ewing sarcoma: four pediatric examples |
Q37935534 | Modeling sarcomagenesis using multipotent mesenchymal stem cells |
Q36651015 | Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors |
Q39650171 | Potential molecular targets for Ewing's sarcoma therapy |
Q38996845 | RUNX3 facilitates growth of Ewing sarcoma cells |
Q38977714 | Targeted polytherapy in small cell sarcoma and its association with doxorubicin |
Q36011879 | Targeted therapy in Ewing sarcoma |
Q41303735 | Targeting the p53 Pathway in Ewing Sarcoma. |
Q92865421 | Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies |
Q35573610 | The cell cycle regulator CCDC6 is a key target of RNA-binding protein EWS. |
Q38218534 | The ets transcription factor Fli-1 in development, cancer and disease |
Q41051759 | miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor |
Q39465507 | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy |
Q44832395 | p53 and hepatoma-derived growth factor expression and their clinicopathological association with Ewing family tumour |
Search more.